Practices in non-neutropenic ICU patients with Candida-positive airway specimens

Intensive Care Medicine

Volumn 30, Issue 7, 2004, Pages 1384-1389

  Azoulay, Elie ^a   Cohen, Yves ^b   Zahar, Jean Ralph ^c   Garrouste Orgeas, Maité ^d   Adrie, Christophe ^e   Moine, Pierre ^f   De Lassence, Arnaud ^g   Timsit, Jean François ^h  

^a SAINT LOUIS HOSPITAL   (France)

^b AVICENNE HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d SAINT JOSEPH HOSPITAL   (France)

^e CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE MONTRÉAL   (Canada)

^f HÔPITAL LARIBOISIÈRE   (France)

^g HÔPITAL LOUIS MOURIER   (France)

^h BICHAT HOSPITAL   (France)

Author keywords

Candida; Diagnosis; Intensive Care Unit; Nosocomial pneumonia; Survey; Treatment

Indexed keywords

ANTIFUNGAL AGENT; PYRROLE DERIVATIVE;

ARTICLE; ARTIFICIAL VENTILATION; CANDIDA; CANDIDIASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; PNEUMONIA; QUESTIONNAIRE; TREATMENT OUTCOME;

EID: 3242697652     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-004-2316-3     Document Type: Article

References (32)

1. Bodey GP (1984) Candidiasis in cancer patients. Am J Med 77:13-19
2. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34:7-14
3. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP (1989) Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 149:2349-2353
4. Petri MG, Konig J, Moecke HP, Gramm HJ, Barkow H, Kujath P, Dennhart R, Schafer H, Meyer N, Kalmar P, Thulig P, Muller J, Lode H (1997) Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Med 23:317-325
5. Eubanks PJ, de Virgilio C, Klein S, Bongard F (1993) Candida sepsis in surgical patients. Am J Surg 166:617-619; discussion 619-20
6. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751-758
7. Eggimann P, Pittet D (2001) Candidiasis among non-neutropenic patients: from colonization to infection. Ann Fr Anesth Reanim 20:382-388
8. Masur H, Rosen PP, Armstrong D (1977) Pulmonary disease caused by Candida species. Am J Med 63:914-925
9. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274:639-644
10. Stephan F, Yang K, Tankovic J, Soussy CJ, Dhonneur G, Duvaldestin P, Brochard L, Brun-Buisson C, Harf A, Delclaux C (2002) Impairment of polymorphonuclear neutrophil functions precedes nosocomial infections in critically ill patients. Crit Care Med 30:315-322
11. Kox WJ, Volk T, Kox SN, Volk HD (2000) Immunomodulatory therapies in sepsis. Intensive Care Med 26:S124-128
12. Jarvis WR (1995) Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 20:1526-1530
13. Eggimann P, Francioli P, Bille J, Schneider R, Wu MM, Chapuis G, Chiolero R, Pannatier A, Schilling J, Geroulanos S, Glauser MP, Calandra T (1999) Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 27:1066-1072
14. Vincent JL, Anaissie E, Bruining H, Demajo W, el-Ebiary M, Haber J, Hiramatsu Y, Nitenberg G, Nystrom PO, Pittet D, Rogers T, Sandven P, Sganga G, Schaller MD, Solomkin J (1998) Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 24:206-216
15. Fernandez-Sola J, Junque A, Estruch R, Monforte R, Torres A, Urbano-Marquez A (1995) High alcohol intake as a risk and prognostic factor for community-acquired pneumonia. Arch Intern Med 155:1649-1654
16. Wheat LJ (1980) Infection and diabetes mellitus. Diabetes Care 3:187-197
17. Haron E, Vartivarian S, Anaissie E, Dekmezian R, Bodey GP (1993) Primary Candida pneumonia. Experience at a large cancer center and review of the literature. Medicine (Baltimore) 72:137-142
18. Rose HD, Sheth NK (1978) Pulmonary candidiasis. A clinical and pathological correlation. Arch Intern Med 138:964-965
19. Azoulay E, Limal N, Mayaud C, Schlemmer B (2001) Bronchial specimens positive to Candida: infection or colonization. Réanimation Urgences 10:323-328
20. el-Ebiary M, Torres A, Fabregas N, de la Bellacasa JP, Gonzalez J, Ramirez J, del Bano D, Hernandez C, Jimenez de Anta MT (1997) Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study. Am J Respir Crit Care Med 156:583-590
21. Rello J, Esandi ME, Diaz E, Mariscal D, Gallego M, Valles J (1998) The role of Candida sp isolated from bronchoscopic samples in non-neutropenic patients. Chest 114:146-149
22. Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JE (2000) Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis 30:662-678
23. Ahmed NA, McGill S, Yee J, Hu F, Michel RP, Christou NV (1999) Mechanisms for the diminished neutrophil exudation to secondary inflammatory sites in infected patients with a systemic inflammatory response (sepsis). Crit Care Med 27:2459-2468
24. Calandra T, Marchetti O (2002) Antifungal prophylaxis for intensive care unit patients: let's fine tune it. Intensive Care Med 28(12):1698-1700
25. Garbino J, Lew D, Romand JA, Hugonnet S, Auckenthaler R, Pittet D (2002) Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients. A randomized, double-blind, placebo-controlled trial in SDD-treated patients. Intensive Care Med 28(12):1708-1717
26. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP (2002) Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 35:627-630
27. Rangel-Frausto MS, Wiblin T, Blumberg HM, Saiman L, Patterson J, Rinaldi M, Pfaller M, Edwards JE, Jarvis W, Dawson J, Wenzel RP (1999) National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 29:253-258
28. Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H, Shadduck RK, Shea TC, Stiff P, Friedman DJ et al (1992) A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 326:845-851
29. Winston DJ, Chandrasekar PH, Lazarus HM, Goodman JL, Silber JL, Horowitz H, Shadduck RK, Rosenfeld CS, Ho WG, Islam MZ et al (1993) Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. Ann Intern Med 118:495-503
30. Pelz RK, Hendrix CW, Swoboda SM, Diener-West M, Merz WG, Hammond J, Lipsett PA (2001) Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 233:542-548
31. Rex JH, Sobel JD (2001) Prophylactic antifungal therapy in the intensive care unit. Clin Infect Dis 32:1191-1200
32. Chen KY, Ko SC, Hsueh PR, Luh KT, Yang PC (2001) Pulmonary fungal infection: emphasis on microbiological spectra, patient outcome, and prognostic factors. Chest 120:177-184